Fmr LLC Sangamo Therapeutics, Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Fmr LLC holds 466,971 shares of SGMO stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

466,971

Previous 436,655 6.94%

Holding current value

$1.34 Million

Previous $292,000 42.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.36 - $0.65 $10,913 - $19,705	30,316 Added 6.94%	466,971 $168,000
Q1 2024 May 13, 2024	BUY	$0.42 - $1.38 $52,551 - $172,669	125,123 Added 40.16%	436,655 $292,000
Q4 2023 Feb 13, 2024	BUY	$0.3 - $0.63 $7,585 - $15,929	25,285 Added 8.83%	311,532 $168,000
Q3 2023 Nov 13, 2023	SELL	$0.58 - $1.47 $1,418 - $3,594	-2,445 Reduced 0.85%	286,247 $171,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $182,995 - $286,858	164,861 Added 133.13%	288,692 $375,000
Q1 2023 May 11, 2023	BUY	$1.66 - $3.67 $5,013 - $11,083	3,020 Added 2.5%	123,831 $217,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $6,395 - $11,706	-2,309 Reduced 1.88%	120,811 $379,000
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $13,036 - $19,508	3,053 Added 2.54%	123,120 $604,000
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.21 $2,138 - $4,048	652 Added 0.55%	120,067 $497,000
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $199,200 - $297,848	38,088 Added 46.83%	119,415 $694,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $1.63 Million - $2.45 Million	-223,023 Reduced 73.28%	81,327 $610,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $507,965 - $677,099	-56,378 Reduced 15.63%	304,350 $2.74 Million
Q2 2021 Aug 13, 2021	BUY	$10.17 - $12.64 $3.67 Million - $4.56 Million	360,728 New	360,728 $4.32 Million

Others Institutions Holding SGMO

# of Institutions

137

Shares Held

85.9M

Call Options Held

35.9K

Put Options Held

156K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $449M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account